Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
75IU
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Multaq is an antiarrhythmic medication primarily used to treat atrial fibrillation and atrial flutter. It belongs to the class of drugs known as Class III antiarrhythmics, which work by prolonging the duration of action potentials and refractory periods in cardiac tissue, helping stabilize the heart's rhythm.
Multaq is specifically designed to reduce the risk of cardiovascular events and hospitalization in patients with a history of atrial fibrillation or flutter.
Fact Table | |
---|---|
Formula | Not applicable (biological preparation containing FSH and LH) |
License | FDA approved |
Bioavailability | Approximately 60-70% (subcutaneous administration) |
Legal status | Prescription only |
Chemical Name | Not applicable (contains naturally derived hormones FSH and LH) |
Elimination half-life | FSH: Approximately 30 hours LH: Approximately 12 hours |
Dosage (Strength) | 75 IU FSH and 75 IU LH per vial (various dosing regimens) |
Pregnancy | Category X (contraindicated in pregnancy) |
Brands | Menopur |
Protein binding | Not well-defined |
PubChem CID | Not available |
MedlinePlus | a682922 |
ChEBI | Not applicable |
ATC code | G03GA02 |
DrugBank | DB00058 |
KEGG | D05691 |
Routes of administration | Subcutaneous, Intramuscular |
The usual dosage is 400 mg by mouth twice daily with or without food, as prescribed by a healthcare professional.
It is important to follow the dosage instructions carefully and to continue taking Multaq even if symptoms improve unless otherwise directed by a doctor.
The active ingredient in Multaq is dronedarone.
Common drug-drug interactions may include:
Use caution if you have a history of severe hepatic impairment or certain heart conditions such as heart block or sinus bradycardia.
Tell your doctor if you are pregnant or breastfeeding.
Regular liver function and heart rhythm monitoring may be necessary during treatment with Multaq.
Common adverse reactions to this drug may include:
Multaq [package insert]. Bridgewater, NJ: Sanofi; July 2009.